EKF Diagnostics Holdings plc
("EKF", the "Company")
Notice of results
Investor results presentation
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical diagnostics business, announces that it will release its interim results for the six months ended 30 June 2017 on Monday 11 September 2017.
Investor briefing
A briefing for all investors will take place on Monday 11 September at Côte Brasserie, 26 Ludgate Hill, London, EC4M 7DR from 4.30pm for a 4.45pm start, and will be followed by drinks and an opportunity to network. If you would like to register for the investor presentation, please contact Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com
|
EKF Diagnostics Holdings plc |
|
|
Christopher Mills, Non-Executive Chairman |
Tel: 029 2071 0570 |
|
Julian Baines, CEO |
|
|
Richard Evans, FD & COO |
|
|
|
|
|
|
|
|
N+1 Singer (Nomad & Broker) |
Tel: 020 7496 3000 |
|
Alex Price / Shaun Dobson / Ali Laughton-Scott |
|
|
|
|
|
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or ekf@walbrookpr.com |
|
Paul McManus / Lianne Cawthorne |
Mob: 07980 541 893 / 07584 391 303 |